WHO ICTRP trial
Study on the performance and safety of Sentinox in the prevention of acute…
ISRCTN14096939 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN14096939 |
|---|---|
| Public title | Study on the performance and safety of Sentinox in the prevention of acute respiratory infections |
| Scientific title | Post-market, randomized and controlled clinical study to assess the performance and safety of Sentinox in the prevention of acute respiratory infections |
| Primary sponsor | Applied Pharma Research (Switzerland) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Italy |
| Conditions | Acute respiratory infections Respiratory |
| Interventions | This is a post-market, randomized and controlled clinical study to assess the performance and safety of Sentinox in the prevention of ARI in a normal healthy population. The study will consist of: 1. A screening visit (Visit 0, on-site) to… |
| Registration date | Aug 18, 2022 |
| Target size | 1458 |
| Secondary IDs | Nil known;Nil known;STX-2022 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: